Clinical Trials Browser

Phase 2 × Recurrence × tipifarnib × Clear all

NCT02464228 2024-06-26

PTCL

Phase 2 Completed

65 enrolled 16 charts

Lymphoma, Recurrence, Lymphoma, T-Cell, Peripheral, Lymphoma, Extranodal NK-T-Cell

NCT00847223 2018-08-23

Efficacy and Safety of the Farnesyl-transferase Inhibitor (Tipifarnib) in Mantle Cell Lymphoma

Phase 2 Terminated

Lymphoma, Recurrence, Lymphoma, Mantle-Cell

NCT00354146 2011-02-01

A Phase 2 Study of Farnesyl Transferase Inhibitor (R115777, Tipifarnib) in Patients With Refractory or Relapsed Acute Myeloid Leukemia.

Phase 2 Completed

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute